Eltacin, 30 pcs.

Eltacin is a combined preparation containing a mixture of substituted amino acids: glycine, glutamic acid and cystine, which are metabolism regulators: increasing intracellular glutathione concentration and glutathione-dependent enzyme activity, normalizing redox processes and oxygen utilization in tissues, due to which the drug:

• exhibits antioxidant (reducing free radicals, peroxide compounds, malonic dialdehyde) and antihypoxant (increasing the body’s resistance to oxygen deficiency, increasing the synthesis of adenosine triphosphoric acid (ATP)) action;
• increases myocardial contractility;
• increases physical performance;
• improves the quality of life of patients with chronic heart failure (increasing social adaptation, improving psychoemotional state);
• accelerates the recovery of performance after intense physical activity in children.

.

Indications

Chronic heart failure of functional class I-III according to the NYHA classification in adults (against the background of standard therapy).
Chronic heart failure of functional class I-II according to the NYHA classification in children aged 12 to 18 years (against the background of standard therapy).
Autonomic dysfunction syndrome in children aged 12 to 18 years.
Prevention of chronic physical overstrain and recovery after intense physical activity during sports in children aged 11 to 15 years.

Pharmacological effect

Eltacin is a combination drug that contains a mixture of non-essential amino acids: glycine, glutamic acid and cystine, which are metabolic regulators: increasing the intracellular concentration of glutathione and the activity of glutathione-dependent enzymes, normalizing redox processes and oxygen utilization in tissues, due to which the drug:

exhibits antioxidant (reducing the content of free radicals, peroxide compounds, malondialdehyde) and antihypoxic (increasing the body’s resistance to oxygen deficiency, enhancing the synthesis of adenosine triphosphoric acid (ATP)) effect;
increases myocardial contractility;
increases physical performance;
improves the quality of life of patients with chronic heart failure (increasing social adaptation, improving psycho-emotional state);
accelerates recovery of performance after intense physical activity in children.

Active ingredient

Glycine, Glutamic acid, Cystine

Composition

1 sublingual tablet contains:

active ingredients:

glycine 70 mg,

L-glutamic acid 70 mg,

L-cystine 70 mg,

excipients:

water-soluble methylcellulose 7.8 mg;

magnesium stearate 2.2 mg

Pregnancy

Clinical studies of the use of the drug in pregnant women and during lactation have not been conducted.

Not recommended for use during pregnancy and lactation.

Contraindications

Hypersensitivity to the drug Eltacin, children under 11 years of age (efficacy and safety have not been established).

Side Effects

Allergic reactions are possible.

Interaction

Can be taken simultaneously with angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, aldosterone antagonists, organic nitrates and slow calcium channel blockers.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C

Shelf life

2 years

Manufacturer

Biotics, Russia